Policy & Regulation

EU Commission proposes €100 billion for science

Read more

Innovation spreads across the oncology sector

Read more

Building a European capital market

Read more

How GMO rules affect gene and cell therapies

Read more

MedNous Briefing: FDA policy on digital health

Read more

The rise of single-arm studies in oncology

Read more

Managing the EMA Relocation

Read more

Regulatory challenges for cell therapy manufacture

Read more

EU examines incentives for the pharma industry

Read more

The risks of therapeutic genome editing

Read more